Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$3.5 - $9.63 $85,484 - $235,203
-24,424 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$6.53 - $14.42 $159,488 - $352,194
24,424 New
24,424 $290,000
Q2 2019

Aug 14, 2019

SELL
$6.0 - $9.0 $77,016 - $115,524
-12,836 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$7.14 - $9.85 $91,649 - $126,434
12,836 New
12,836 $116,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $190M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Ironwood Investment Management LLC Portfolio

Follow Ironwood Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.